Lahiri, Satadru K.
Quick, Ann P.
Samson-Couterie, Benoit
Hulsurkar, Mohit
Elzenaar, Ies
van Oort, Ralph J.
Wehrens, Xander H. T.
Funding for this research was provided by:
National Heart, Lung, and Blood Institute (HL091947, HL089598, HL117641, T32HL07676)
Hartstichting (2012T094)
American Heart Association (18POST34080154)
Heart Rhythm Society
Article History
Received: 18 February 2020
Accepted: 12 June 2020
First Online: 26 June 2020
Compliance with ethical standards
:
: XHTW is a founding partner of Elex Biotech, a start-up company that develops drug molecules that target ryanodine receptors for the treatment of cardiac arrhythmia disorders.